...
首页> 外文期刊>Pharmaceutical Nanotechnology >Meloxicam-loaded Phospholipid/solutol? HS15 Based Mixed Nanomicelles: Preparation, Characterization,and in vitro Antioxidant Activity
【24h】

Meloxicam-loaded Phospholipid/solutol? HS15 Based Mixed Nanomicelles: Preparation, Characterization,and in vitro Antioxidant Activity

机译:载有美洛昔康的磷脂/溶剂油吗?基于HS15的混合Nanomicelles:制备,表征和体外抗氧化活性

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: Rheumatoid arthritis (RA) is a debilitating disease which results in joint destruction, mainly due to chronic inflammation and oxidative stress. Meloxicam (MLX) is a preferential cyclooxygenase-2 (COX-2) inhibitor with potential free radical scavenging activity. Mixed nanomicelles (NMs) of MLX can augment its antioxidant effects. Objective: The present study aims to prepare, characterize, and evaluate the in vitro antioxidant effects of MLX-loaded mixed nanomicelles (MLX-NMs). Method: Conventional thin-film hydration method was employed to fabri-cate MLX-NMs. The formulations were characterized for particle size, zeta potential, entrapment efficiency (EE), and drug loading (DL). Additionally, the optimized formulation was characterized for small-angle neutron scattering (SANS), in vitro drug release, and morphology. MLX encapsulation in NMs was confirmed by Fourier Transform Infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), 1H nuclear magnetic resonance (NMR), and X-ray diffraction (XRD), studies. The cell uptake of sulforhodamine В (SRB)-labeled NMs was studied in RAW 264.7 cells. The in vitro antioxidant activity of optimized MLX-NMs was studied by different antioxidant assays. Results: The optimized MLX-NMs exhibited average size and zeta potential of 88 ± 42 nm and-47.4 士 16.2 mV, respectively. The EE and DL of MLX were 94.13 士 1.01 % and 4.20 ± 0.05 %,respectively. Morphology studies confirmed the oblate ellipsoidal shape of MLX-NMs. The in vitro release study exhibited a biphasic release pattern. MLX encapsulation into the micelle core was confirmed by FTIR, DSC, NMR, and XRD studies. Additionally, SRB-labeled NMs demonstrated efficient in vitro cell uptake in RAW 264.7 cells. Furthermore, in vitro antioxidant studies exhibited superior free radical scavenging activity of MLX-NMs as compared to free MLX. Conclusion: The NMs potentiate the in vitro antioxidant effects of MLX.
机译:背景:类风湿关节炎(RA)是一种使人衰弱的疾病,主要由于慢性炎症和氧化应激而导致关节破坏。美洛昔康(MLX)是一种优先的环氧合酶2(COX-2)抑制剂,具有潜在的自由基清除活性。 MLX的混合纳米胶束(NMs)可以增强其抗氧化作用。目的:本研究旨在制备,表征和评估载有MLX的混合纳米胶束(MLX-NMs)的体外抗氧化作用。方法:采用常规的薄膜水化法制备MLX-NM。对制剂的粒径,ζ电势,包封率(EE)和载药量(DL)进行表征。此外,针对小角中子散射(SANS),体外药物释放和形态对优化配方进行了表征。通过傅立叶变换红外光谱(FTIR),差示扫描量热法(DSC),1H核磁共振(NMR)和X射线衍射(XRD)研究证实了MLX在NMs中的封装。在RAW 264.7细胞中研究了磺基若丹明(SRB)标记的NMs的细胞摄取。通过不同的抗氧化剂试验研究了优化的MLX-NMs的体外抗氧化剂活性。结果:优化的MLX-NMs的平均大小和Zeta电位分别为88±42 nm和-47.4士16.2 mV。 MLX的EE和DL分别为94.13士1.01%和4.20±0.05%。形态学研究证实了MLX-NM的扁椭圆形。体外释放研究显示出双相释放模式。通过FTIR,DSC,NMR和XRD研究证实将MLX封装到胶束核心中。此外,SRB标记的NMs在RAW 264.7细胞中显示出有效的体外细胞摄取。此外,体外抗氧化剂研究显示,与游离MLX相比,MLX-NM具有更好的自由基清除活性。结论:NMs增强了MLX的体外抗氧化作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号